¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"MYO"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • G70.9
    Myoneural disorder, unspecified
    »ó¼¼ºÒ¸íÀÇ ±Ù½Å°æ¼º Àå¾Ö
  • G72.2
    Myopathy due to other toxic agents
    ±âŸ µ¶¼º¹°Áú¿¡ ÀÇÇÑ ±ÙÀ°º´Áõ
  • G73.5*
    Myopathy in endocrine diseases
    ³»ºÐºñ¼º Áúȯ¿¡¼­ÀÇ ±ÙÀ°º´Áõ
  • G73.4*
    Myopathy in infectious and parasitic diseases classified elsewhere
    ´Þ¸® ºÐ·ùµÈ °¨¿°¼º ¹× ±â»ýÃæ¼º Áúȯ¿¡¼­ÀÇ ±ÙÀ°º´Áõ
  • G73.6*
    Myopathy in metabolic diseases
    ´ë»ç¼º Áúȯ¿¡¼­ÀÇ ±ÙÀ°º´Áõ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • myoclonic epilepsy
    ±Ù(À°)°£´ë°£Áú
  • myoclonic seizure
    °£´ë¼º±Ù(À°)°æ·Ã¹ßÀÛ
  • myoclonus
    ±Ù(À°)°£´ë°æ·Ã
  • myoclonus multiplex
    ´Ù¹ß±Ù(À°)°£´ë°æ·Ã
  • myocolpitis
    Áú±Ù¿°, Áú±ÙÀ°Ãþ¿°
  • myocutaneous
    ±Ù(À°)ÇǺÎ-
  • myocutaneous flap
    ±ÙÀ°ÇÇºÎÆÇ, ±ÙÇÇÆÇ
  • myocyte
    ±Ù(À°)¼¼Æ÷
  • myocytolysis
    ±Ù(À°)¼¼Æ÷À¶ÇØ
  • myodegeneration
    ±Ù(À°)º¯¼º
  • myodesopsia
    ³¯ÆÄ¸®Áõ, ºñ¹®Áõ
  • myodiastasis
    ±Ù(À°)ºÐ¿­, ±Ù¿­
  • myodiopter
    ±Ùµð¿ÉÅÍ
  • myodynamic
    ±Ù¿îµ¿¼º-, ±Ù·Â-
  • myodynamometer
    ±Ù·Â°è
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 4 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • myospasm
    ±ÙÀ°¿¬Ãà
  • myotomy
    ±ÙÀ°Àý°³(¼ú), ±ÙÀý´Ü(¼ú)
  • myotonia
    ±ÙÀ°±äÀåÁõ, ±Ù°­Á÷Áõ
  • myotonic
    ±ÙÀ°±äÀå-
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • myocelialgia
    ¹è±ÙÀ°ÅëÁõ, º¹±ÙÅë
  • myocellulitis
    ±ÙÀ°¹úÁý¿°, ±ÙºÀ¼Ò¿°
  • myochrome
    ±ÙÀ°»ö¼Ò
  • myoclonia
    (¢¡myoclonus) °£´ë¼º±Ù°æ·ÃÁõ
  • myoclonia fibrillaris multiplex
    ´Ù¹ßÀܶ³¸²±Ù´ë¼º´ë¹ßÀÛ
  • myoclonic contraction
    ±ÙÀ°Å¬·Î´©½º¼öÃà
  • myoclonic convulsion
    ±ÙÀ°Å¬·Î´©½º°æ·Ã
  • myoclonic epilepsy
    °£´ë¼º±Ù°æ·Ã°£Áú
  • myoclonic seizure
    °£´ë¼º±Ù°æ·Ã¹ßÀÛ
  • myoclonic twitch
    °£´ë¼º±Ù°æ·Ã¼öÃà
  • myoclonus
    °£´ë¼º±Ù°æ·ÃÁõ
  • myoclonus multiplex
    ´Ù¹ß±Ù´ë¼º´ë¹ßÀÛ
  • myocolpitis
    Áú±ÙÀ°¿°
  • myocutaneous flap
    (¢¡musculocutaneous flap) ±ÙÀ°ÇÇºÎÆÇ, ±ÙÀ°ÇÇÆÇ
  • myocyte
    ±ÙÀ°¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • myocardial disease
    ½É±ÙÁúȯ(¡­òðü´).
  • myocardial disease
    ½É±ÙÁúȯ(¡­òðü´)
  • myocardial failure
    ½É±ÙºÎÀü(¡­ÝÕîï).
  • myocardial fibrosis
    ½É±Ù¼¶À¯Áõ(¡­àéë«ñø).
  • myocardial function
    ½É±Ù±â´É.
  • myocardial hypoxia
    ½É±ÙÀú»ê¼ÒÁõ(ãýÐÉî¸ß«áÈñø).
  • myocardial infarction
    ½É±Ù°æ»öÁõ(¡­ÌÛßáñø).
  • myocardial infarction
    ½É±Ù°æ»öÁõ(¡­ÌÛßáñø)
  • myocardial infarction
    ½É±Ù°æ»ö
  • myocardial infarction,complications of
    ÇÕº´Áõ(ùêܱñø)
  • myocardial infarction,exogeneous estrogens
    ¿ÜÀμº ¿¡½ºÆ®·Î°Õ(èâì×àõ ¡­)
  • myocardial infarction,extension
    ½ÅÀü(ãßî÷)
  • myocardial infarction,outcomes of
    °á¸»(Ì¿ØÇ)
  • myocardial infarction,transmural
    ÀüÃþ°æ»öÁõ(îïöµÌÛßáñø)
  • myocardial infarction,ventricular aneurysm
    ½É½Ç·ù(ãýãø×µ)
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • myocardium
    ½É±Ù, ½É±ÙÃþ
  • myocardium,aging effect
    ³ëÈ­ Çö»ó
  • myocardosis
    ½É±ÙÁõ
    ºñ¿°Áõ»óÀÇ ½É±Ù Ãþ Àå¾Ö¿¡ ´ëÇÑ ÀÏ¹Ý ¿ë¾î·Î¼­, °íÇ÷¾ÐÁõ, °ü»ó µ¿¸Æ°æÈ­, °©»ó¼± ±â´É Ç×Áø¿¡ ±âÀÎÇÑ´Ù.
  • myocelialgia
    º¹±ÙÅë
  • myocellulitis
    ±Ù ºÀ¿ÍÁ÷¿°
  • myoceptor
    ±Ù ¼ö¿ë±â
  • myocerosis
    ±Ù¶ø¾ç º¯¼º
    ±ÙÀ°ÀÇ ³³¾ç º¯¼º.
  • myochrome
    ±Ù»ö¼Ò
    ±Ù»ö¼Ò ±º¿¡ ¼ÓÇÏ´Â ¸ðµç »ö¼Ò.
  • myocinesimeter
    ±Ù ¿îµ¿ ±â·Ï°è
  • myoclonic contraction
    ±Ù°£´ë¼º ¿¬Ãà
  • myoclonic dementia
    ¹Ì¿ÀŬ·Î´©½º Ä¡¸Å
  • myoclonic epilepsy and raggedred fibers
    °£´ë ±ÙÀ° °æ·Ã¼º °£Áú
  • myoclonus
    °£´ë¼º ±Ù°æ·Ã
    1. ¸Å¿ì ª°í ºÒ¼öÀÇÀûÀÌ¸ç ºÒ±ÔÄ¢ÇÑ ±Ù¼öÃàÀÌ´Ù. ÈÞÁö±â¿¡ ÀÚ¹ßÀûÀ¸·Î ÀÚ±Ø °¨°¢¿¡ ¹ÝÀÀÇÏ¿© ¶Ç´Â ¼öÀÇÀû ¿îµ¿À¸·Î ³ªÅ¸³¯ ¼ö ÀÖ´Ù. 2. Çϳª³ª ±× ÀÌ»óÀÇ ±ÙÀ°±ºÀÇ ¼öÃàÀ¸·Î ÀÎÇÑ °£´ë¼ºÀÇ °æ·ÃÀ̳ª ¿¬Ãà.
  • myoclonus multiplex
    ´Ù¹ß¼º ±¸°£´ë °æ·Ã, ´Ù¹ß¼º ±¸°£´ë °æ·ÃÁõ
  • myocomma
    ±ÙÀý °Ý¸·
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
myocardial necrosis Irreversible destruction of myocardial (heart muscle) cells.
(27 Sep 1997)
myocardial perfusion imaging <radiology> (thallium scanning) thallium (Tl) 201, acts as potassium analog, dose 2.0 - 3.0 mCi at peak exercise, 4% of injected dose reaches myocardium, imaging: exercise (1-5 min), redistribution (3-4 hrs), views: anterior, LAO 45', left lateral, interpretation: normal, reversible abnormalitymost likely to be exercise-induced ischemia, nonreversible abnormalitymost likely to be prior myocardial infarction, reverse redistribution most likely to be normal areas wash out faster, lung activity most likely to be LV failure during exercise see also: dipyridamole test, nuclear cardiology
(12 Dec 1998)
myocardial reperfusion Generally, restoration of blood supply to heart tissue which is ischemic due to decrease in normal blood supply. The decrease may result from any source including atherosclerotic obstruction, narrowing of the artery, or surgical clamping. Reperfusion can be induced to treat ischemia. Methods include chemical dissolution of an occluding thrombus, administration of vasodilator drugs, angioplasty, catheterization, and artery bypass graft surgery. However, it is thought that reperfusion can itself further damage the ischemic tissue, causing myocardial reperfusion injury.
(12 Dec 1998)
myocardial reperfusion injury Functional, metabolic, or structural changes in ischemic heart muscle thought to result from reperfusion to the ischemic areas. Changes can be fatal to muscle cells and may include oedema with explosive cell swelling and disintegration, sarcolemma disruption, fragmentation of mitochondria, contraction band necrosis, enzyme washout, and calcium overload. Other damage may include haemorrhage and ventricular arrhythmias. One possible mechanism of damage is thought to be oxygen free radicals. Treatment currently includes the introduction of scavengers of oxygen free radicals, and injury is thought to be prevented by warm blood cardioplegic infusion prior to reperfusion.
(12 Dec 1998)
myocardial revascularization The restoration of blood supply to the myocardium.
(12 Dec 1998)
myocardial rigor mortis Irreversible contraction of the left ventricle of the heart as a complication seen in the early period of cardiopulmonary bypass and now avoided by appropriate cardioplegic solutions.
Synonym: myocardial rigor mortis, stone heart.
(05 Mar 2000)
myocardial stunning Prolonged dysfunction of the myocardium after a brief episode of severe ischemia, with gradual return of contractile activity. It occurs frequently, both in the experimental laboratory and in clinical medicine. Since stunned myocardium occurs adjacent to necrotic tissue after prolonged coronary occlusion, many myocardial infarcts may be a mixture of necrotic and stunned tissue.
(12 Dec 1998)
myocardiograph An instrument composed of a tambour with recording lever attachment, by means of which a tracing is made of the movements of the heart muscle.
Origin: myo-+ G. Kardia, heart, + grapho, to record
(05 Mar 2000)
myocardiopathy Synonym: cardiomyopathy.
Origin: myocardium + G. Pathos, suffering
(05 Mar 2000)
myocardiorrhaphy Suture of the myocardium.
Origin: myocardium + G. Rhaphe, suture
(05 Mar 2000)
myocarditic Related to myocarditis (adjective).
(05 Mar 2000)
myocarditis <cardiology, pathology> Inflammation of the myocardium, inflammation of the muscular walls of the heart.
Origin: Gr. Kardia = heart
(18 Nov 1997)
myocardium <anatomy> A term used to describe the middle layer of the heart wall (heart muscle).
(27 Sep 1997)
myocardosis An obsolete term for a condition marked by symptomatic signs of cardiac trouble without any discoverable pathologic lesion and for any degenerative condition of the heart muscle except myofibrosis.
(05 Mar 2000)
myocele 1. Protrusion of muscle substance through a rent in its sheath.
Origin: myo-+ G. Kele, hernia
2. The small cavity that appears in somites.
Synonym: somite cavity.
Origin: myo-+ G. Koilia, a cavity
(05 Mar 2000)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 3
  • Myocardial Reperfusion Injury - »õâ Damage to the MYOCARDIUM resulting from reperfusion of ischemic areas of the HEART. Reperfusion takes place when there is spontaneous thrombolysis, THROMBOLYTIC THERAPY, collateral flow from other coronary vascular beds, or reversal of vasospasm. Reperfusion can cause EDEMA, injuries to cardiac myocytes (MYOCYTES, CARDIAC) and the conducting tissue with resultant ARRHYTHMIA. Degree of injury depends on the duration and extent of MYOCARDIAL ISCHEMIA before reperfusion, cytosolic calcium overload, and oxygen FREE RADICALS.
    Synonyms : Injury, Myocardial Reperfusion, Myocardial Ischemic Reperfusion Injury, Injuries, Myocardial Reperfusion, Myocardial Reperfusion Injuries, Reperfusion Injuries, Myocardial
  • Myocardial Revascularization - »õâ The restoration of blood supply to the myocardium. (From Dorland, 28th ed)
    Synonyms : Myocardial Revascularizations, Revascularization, Myocardial, Revascularizations, Myocardial
  • Myocardial Stunning - »õâ Prolonged dysfunction of the myocardium after a brief episode of severe ischemia, with gradual return of contractile activity. It occurs frequently, both in the experimental laboratory and in clinical medicine. Since stunned myocardium occurs adjacent to necrotic tissue after prolonged coronary occlusion, many myocardial infarcts may be a mixture of necrotic and stunned tissue. (Braunwald, Heart Disease, 1992, p1176)
    Synonyms : Myocardium, Stunned, Stunning, Myocardial
  • Myocarditis - »õâ Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.
    Synonyms : Myocarditides
  • Myocardium - »õâ The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow.
    Synonyms : Cardiac Muscle, Myocardia, Cardiac Muscles, Heart Muscle, Heart Muscles, Muscles, Cardiac, Muscles, Heart
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
myogram a graphical recording of muscle activity
Ãâó: wordnet.princeton.edu/perl/webwn
myoid resembling muscle
Ãâó: wordnet.princeton.edu/perl/webwn
myology the branch of physiology that studies muscles
Ãâó: wordnet.princeton.edu/perl/webwn
myoma a benign tumor composed of muscle tissue
Ãâó: wordnet.princeton.edu/perl/webwn
myometritis inflammation of the myometrium
Ãâó: wordnet.princeton.edu/perl/webwn
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 12 ÆäÀÌÁö: 3
MYO the junction between a nerve fiber and the muscle it supplies
MYO of or relating to any disease of the muscles that is not caused by nerve dysfunction
MYO any pathology of the muscles that is not attributable to nerve dysfunction
MYO a person with myopia
MYO (ophthalmology) eyesight abnormality resulting from the eye's faulty refractive ability
MYO lacking foresight or scope
MYO (ophthalmology) sharp vision nearby but an inability to focus on distant objects
MYO a genus of Cricetidae
MYO sarcoma of muscle tissue
MYO the commonest protein in muscle
MYO reflex contraction of the sphincter muscle of the iris in response to a bright light (or certain drugs) causing the pupil to become smaller
MYO an acute infectious disease occurring in epidemic form and featuring paroxysms of pain (usually in the chest)
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 3
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á